Dataset ID
JGAD000721
- Type of data
- target sequencing of 27 cancer-predisposing genes in 37,592 controls
- Access criteria
- Controlled-access (Type I)
- Total data volume
- 2.8 TB
- File formats
- FASTQ
- Research
- hum0014
- Date published
- 2023-05-01
- Date modified
- 2026-05-13
- DDBJ Search
- JGAD000721 (opens in a new tab)
- JGA Study
- JGAS000592 (opens in a new tab)
Analysis method
Targeted DNA sequencing
- Materials and participants
- 1,005 pancreatic cancer patients (ICD10: C25)
12,503 colorectal cancer patients (ICD10: C18, C19, C20)
740 renal cell cancer patients (ICD10: C64)
1,982 lymphoma patients (ICD10: C81, C82, C83, C84, C85, C86, C88, C91)
10,366 gastric cancer patients (ICD10: C16)
23,705 + 5,996 + 37,592 controls
37,592 controls - Health statusHealthy
- Subject count37,592 (Individual)
- Disease
- pancreatic cancer patients
- colorectal cancer patients
- renal cell cancer patients
- lymphoma patients
- gastric cancer patients
- Sample description
- DNA extracted from peripheral blood cells
- TissuePeripheral blood
- Tumor / normalNormal
- Sample provider
- N/A
- Experimental method
- Targeted DNA sequencing
- Target
- 27 cancer-predisposing genes (APC, ATM, BARD1, BMPR1A, BRCA1, BRCA2, BRIP1, CDK4, CDKN2A, CDH1, CHEK2, EPCAM, HOXB13, NBN, NF1, MLH1, MSH2, MSH6, MUTYH, PALB2, PMS2, PTEN, RAD51C, RAD51D, SMAD4, STK11, TP53)
- Reagent kit
- KAPA HiFi DNA Polymerase
2X Platinum Multiplex PCR Master Mix - Fragmentation
- N/A
- Platform
- Illumina HiSeq 2500
- Read type
- Paired-end
- Read length
- 150 bp
- Data use policy
- NBDC data sharing policy (JGAP000001)